Results 11 to 20 of about 34,976 (197)
Hemostasis and Type 1 Neurofibromatosis
Plastic and Reconstructive Surgery, Global Open, 2017 Jeremy Niddam, MD +4 more
doaj +4 more sources
Neurofibromatosis type 1 [PDF]
Journal of the American Academy of Dermatology, 2009 Neurofibromatosis type 1 (NF1) is an autosomal dominant, multisystem disorder affecting approximately 1 in 3500 people. Significant advances in the understanding of the pathophysiology of NF1 have been made in the last decade. While no medical therapies for NF1 are currently available, trials are ongoing to discover and test medical treatments for the ...
Kevin P, Boyd, Bruce R, Korf, Amy, Theos
openaire +3 more sources
Neurofibromatosis type 1 [PDF]
QJM: An International Journal of Medicine, 2018 The neurofibromatoses are a group of three heterogeneous disorders that include neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2), and schwannomatosis. NF1 is the most common of these three conditions, and represents one of the most frequently diagnosed cancer predisposition disorders involving the nervous system.
Patrick J, Cimino, David H, Gutmann
openaire +4 more sources
[Pheochromocytoma in Neurofibromatosis Type 1]. [PDF]
Probl Endokrinol (Mosk)Neurofibromatosis type 1 is a hereditary disease with a wide variability of clinical manifestations, from the almost complete absence of typical symptoms to a multisystem lesion of the body. One of the possible clinical manifestations of this pathology is a pheochromocytoma — a tumor of the adrenal gland with the possible development of considerable ...
Rebrova DV +17 more
europepmc +3 more sources
Cutaneous Findings in Neurofibromatosis Type 1 [PDF]
Cancers, 2021 Neurofibromatosis type 1 (NF1) is a complex autosomal dominant disorder associated with germline mutations in the NF1 tumor suppressor gene. NF1 belongs to a class of congenital anomaly syndromes called RASopathies, a group of rare genetic conditions caused by mutations in the Ras/mitogen-activated protein kinase pathway.
Bengisu Ozarslan +4 more
openaire +2 more sources
European Journal of Cancer, 1994 European Journal of Cancer 30 (1994) 1974-1981. doi:10.1016/0959-8049(94)00389-M ; Received by publisher: 0000-01-01 ; Harvest Date: 2016-01-04 12:23:06 ; DOI:10.1016/0959-8049(94)00389-M ; Page Range: 1974 ...
The authors are at the Department of Pediatrics, Division of Genetics, Center for Mammalian Genetics S.W. Archer Road, Box 100296, University of Florida, Gainesville, Florida 32610-0296, U.S.A. ( host institution ) +2 more
openaire +3 more sources
Pseudoarthrosis in neurofibromatosis type-1 [PDF]
Postgraduate Medical Journal, 2001 Abstract A 27 year old man presented with multiple papules, nodules, and hyperpigmented spots on the body, which he had had since early childhood. In addition, he had a deformity of the right forearm. Examination revealed multiple large sized café-au-lait macules, axillary freckling, and soft cutaneous neurofibromas (mollusca fibrosa ...
S, Kaur, G P, Thami, A J, Kanwar
openaire +2 more sources
A CASE OF NEUROFIBROMATOSIS TYPE 1 [PDF]
Journal of IMAB, 2008 Neurofibromatosis (NF) is a term that has been applied to a variety of related syndromes, characterized by neuroectodermal tumors arising within multiple organs and autosomal-dominant inheritance.
Valentina Dimitrova +6 more
doaj +1 more source
An innovative resection of giant neurofibromas
Chinese Journal of Plastic and Reconstructive SurgeryBackground: Plexiform neurofibromas (PNF) are highly vascular tumors with the potential for significant growth. Surgical removal of giant PNF is often challenging because of intraoperative hemorrhage.
Zhichao Wang +7 more
doaj +1 more source
Cortical Malformations in Neurofibromatosis Type 1
Pediatric Neurology Briefs, 2004 Different types of malformations of cortical development in three cases of neurofibromatosis 1 (NF1) are reported from the University of Siena, Italy.
J Gordon Millichap
doaj +1 more source